趋化因子及其受体与冠心病关系的研究进展
《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]
- 期数:
- 2015年第2期
- 页码:
- 221-223
- 栏目:
- 综述
- 出版日期:
- 2014-10-25
文章信息/Info
- Title:
- Research progress in the relationship between chemokines and their receptors and coronary heart disease
- Author(s):
- MA Dan-dan; FU Yu; YIN Xin-hua
- (Department of Cardiology, First Affiliated Hospital, Harbin Medical University, Harbin 150001, Heilongjiang, China)
- Keywords:
- atherosclerosis; chemokine; chemokine receptor
- 分类号:
- Q514.3
- DOI:
- -
- 文献标识码:
- A
- 摘要:
- 动脉粥样硬化(AS)是慢性炎性及代谢性疾病，脂质沉积和炎性细胞浸润至血管内皮下是形成AS的主要原因，但是炎性细胞浸润的机制尚未阐明。许多国内外研究表明，趋化因子对单核细胞、巨噬细胞、T细胞等炎性细胞的迁移、活化在AS炎症反应中起重要作用。新近研究证实，趋化因子可促使血管平滑肌细胞增殖以及炎症因子和基质金属蛋白酶的合成，促进斑块不稳定的关键环节。本文就趋化因子及其受体在AS发生发展中的作用予以综述。
- Abstract:
- Atherosclerosis (AS) is a chronic inflammatory condition. The main causes for AS formation are metabolic diseases, lipid deposition and infiltration of inflammatory cells to the vascular endothelium; however, the mechanism of inflammatory infiltration has not yet been elucidated. Many national and international studies have shown that migration and activation of chemokines to monocytes, macrophages, T cells and other inflammatory cells are important in the inflammatory response of AS. Recent studies have demonstrated that chemokines may promote the proliferation and synthesis of inflammatory cytokines and matrix metalloproteinases cells, promoting plaque instability. This article briefly reviews the functions of chemokines and their receptors in AS.
参考文献/References
[1]Wan W,Murphy PM.Regulation of atherogenesis by chemokines and chemokine receptors[J].Arch Immunol Ther Exp (Warsz),2013,61(1):1-14.
[2]Aukrust P,Halvorsen B,Yndestad A,et al.Chemokines and cardiovascular risk[J]. Arterioscler Thromb Vasc Biol,2008,28(11):1909-1919.
[3]Saederup N,Chan L,Lira SA,et al.Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice:evidence for Independent chemokine functions in atherogenesis[J].Circulation,2008,117(13):1642-1648.
[4]Combadière C,Potteaux S,Rodero M,et al.Combined inhibition of CCL2,CX3CR1,and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice[J].Circulation,2008,117(13):1649-1657.
[5]Zhang S,Wang X,Zhang L,et al.Characterization of monocyte chemoattractant proteins and CC chemokine receptor 2 expression during atherogenesis in apolipoprotein E-null mice[J].J Atheroscler Thromb,2011,18(10):846-856.
[6]Maddaluno M,Di Lauro M,Di Pascale A,et al.Monocyte chemotactic protein-3 induces human coronary smooth muscle cell proliferation[J].Atherosclerosis,2011,217(1):113-119.
[7]Stolla M,Pelisek J,von Brühl ML,et al.Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1[J].PLoS One,2012,7(8):e43572.
[8]Poupel L,Boissonnas A,Hermand P,et al.Pharmacological inhibition of the chemokine receptor,CX3CR1,reduces atherosclerosis in mice[J].Arterioscler Thromb Vasc Biol,2013,33(10):2297-2305.
备注/Memo
- 备注/Memo:
- 收稿日期：2014-04-16.
基金项目：国家自然科学基金青年基金项目资助(81200143)；国家自然科学基金青年基金项目资助(81200235)；黑龙江省青年科学基金项目资助(QC2012C015);哈尔滨市科技创新人才研究专项基金项目资助(2012RFXX5008)
通讯作者：尹新华，教授，主要从事冠心病的基础与临床研究 Email:xinhua_yin@163.com
作者简介：马丹丹，硕士生 Email：598955071@ qq.com
常用功能
统计/Statistics
- 摘要浏览/Viewed714
- 评论/Comments
